Zimmer Biomet Holdings ROA 2006-2019 | ZBH

Current and historical return on assets (ROA) values for Zimmer Biomet Holdings (ZBH) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Zimmer Biomet Holdings ROA for the three months ending March 31, 2019 was 6.28%.
Zimmer Biomet Holdings ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2019-03-31 $-0.31B $24.29B -1.24%
2018-12-31 $-0.38B $24.13B -1.48%
2018-09-30 $1.75B $25.38B 6.74%
2018-06-30 $1.69B $25.49B 6.43%
2018-03-31 $1.69B $27.18B 6.37%
2017-12-31 $1.81B $26.01B 6.85%
2017-09-30 $0.65B $26.42B 2.45%
2017-06-30 $0.71B $26.46B 2.66%
2017-03-31 $0.50B $26.99B 1.86%
2016-12-31 $0.31B $26.68B 1.16%
2016-09-30 $0.36B $27.04B 1.37%
2016-06-30 $0.23B $25.97B 0.86%
2016-03-31 $0.08B $26.30B 0.31%
2015-12-31 $0.15B $27.16B 0.59%
2015-09-30 $0.17B $26.69B 0.83%
2015-06-30 $0.32B $27.20B 2.00%
2015-03-31 $0.67B $17.19B 5.81%
2014-12-31 $0.72B $9.66B 7.52%
2014-09-30 $0.83B $9.67B 8.64%
2014-06-30 $0.81B $9.64B 8.52%
2014-03-31 $0.78B $9.38B 8.37%
2013-12-31 $0.78B $9.58B 8.48%
2013-09-30 $0.68B $9.36B 7.49%
2013-06-30 $0.70B $9.10B 7.88%
2013-03-31 $0.77B $8.75B 8.70%
2012-12-31 $0.76B $9.01B 8.64%
2012-09-30 $0.76B $8.78B 8.81%
2012-06-30 $0.77B $8.62B 9.12%
2012-03-31 $0.76B $8.60B 9.09%
2011-12-31 $0.76B $8.52B 9.21%
2011-09-30 $0.64B $8.20B 7.86%
2011-06-30 $0.64B $8.25B 7.90%
2011-03-31 $0.60B $8.12B 7.52%
2010-12-31 $0.60B $8.00B 7.54%
2010-09-30 $0.72B $8.00B 9.12%
2010-06-30 $0.68B $7.83B 8.70%
2010-03-31 $0.72B $7.82B 9.38%
2009-12-31 $0.72B $7.79B 9.52%
2009-09-30 $0.73B $7.65B 9.87%
2009-06-30 $0.80B $7.46B 10.96%
2009-03-31 $0.81B $7.23B 11.40%
2008-12-31 $0.85B $7.24B 12.05%
2008-09-30 $0.95B $7.08B 13.71%
2008-06-30 $0.78B $6.94B 11.54%
2008-03-31 $0.78B $6.92B 11.89%
2007-12-31 $0.77B $6.63B 12.18%
2007-09-30 $0.76B $6.37B 12.20%
2007-06-30 $0.89B $6.32B 14.70%
2007-03-31 $0.86B $6.10B 14.40%
2006-12-31 $0.84B $5.97B 14.05%
2006-09-30 $0.79B $5.91B 13.44%
2006-06-30 $0.78B $5.96B 13.36%
2006-03-31 $0.77B $5.92B 13.43%
2005-12-31 $0.73B $5.72B 13.06%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $25.282B $7.933B
Zimmer Biomet Holdings, Inc. is a musculoskeletal healthcare company. The company design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. Zimmer Biomet Holdings, Inc., formerly known as Zimmer Holdings, Inc., is based in Warsaw, United States.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $154.348B 29.07
Medtronic (MDT) Ireland $135.189B 19.31
Stryker (SYK) United States $77.613B 27.70
Boston Scientific (BSX) United States $58.755B 28.17
Baxter (BAX) United States $42.395B 26.72
EssilorLuxottica Societe Anonyme (ESLOY) France $29.186B 0.00
Coloplast (CLPBY) Denmark $25.855B 41.28
Lonza Group Ag (LZAGY) Switzerland $25.565B 0.00
Terumo (TRUMY) Japan $22.330B 25.68
Smith & Nephew SNATS (SNN) United Kingdom $18.881B 0.00
ResMed (RMD) United States $17.703B 33.83
Sunny Optical Technology (SNPTF) China $12.345B 0.00
Canopy Growth (CGC) Canada $12.272B 0.00
Bio-Rad Laboratories (BIO) United States $9.392B 49.79
William Demant Holdings (WILYY) Denmark $7.263B 0.00
Insulet (PODD) United States $7.231B 526.83
Hill-Rom Holdings (HRC) United States $7.018B 21.27
Perrigo (PRGO) Ireland $7.012B 11.85
Aurora Cannabis (ACB) Canada $6.936B 68.40
GN STORE NORD (GNNDY) Denmark $6.409B 32.73
Haemonetics (HAE) United States $6.251B 51.03
ICU Medical (ICUI) United States $5.188B 30.95
GW Pharmaceuticals (GWPH) United Kingdom $4.991B 0.00
Neogen (NEOG) United States $3.334B 54.21
NuVasive (NUVA) United States $3.016B 24.63
Hutchison China MediTech (HCM) China $2.777B 0.00
Agios Pharmaceuticals (AGIO) United States $2.746B 0.00
National Vision Holdings (EYE) United States $2.480B 52.83
Quidel (QDEL) United States $2.268B 23.54
Aphria (APHA) $1.604B 0.00
Cardiovascular Systems (CSII) United States $1.544B 886.40
Phibro Animal Health (PAHC) United States $1.216B 18.22
AtriCure (ATRC) United States $1.203B 0.00
VAREX IMAGING (VREX) United States $1.174B 24.93
NanoString Technologies (NSTG) United States $1.114B 0.00
Lantheus Holdings (LNTH) United States $1.097B 29.13
PetIQ (PETQ) United States $1.015B 24.66
Quanterix (QTRX) United States $0.779B 0.00
Cerus (CERS) United States $0.761B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.750B 21.03
Omeros (OMER) United States $0.719B 0.00
MacroGenics (MGNX) United States $0.717B 0.00
TG Therapeutics (TGTX) United States $0.681B 0.00
LeMaitre Vascular (LMAT) United States $0.598B 28.97
OraSure Technologies (OSUR) United States $0.530B 24.40
Surmodics (SRDX) United States $0.527B 76.59
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.499B 0.00
Meridian Bioscience (VIVO) United States $0.492B 15.04
BioLife Solutions (BLFS) United States $0.330B 103.12
Utah Medical Products (UTMD) United States $0.321B 22.20
Vapotherm (VAPO) United States $0.320B 0.00
Zynex (ZYXI) United States $0.251B 25.77
Cytosorbents (CTSO) United States $0.242B 0.00
Bovie Medical (APYX) United States $0.214B 0.00
Chimerix (CMRX) United States $0.188B 0.00
Rockwell Medical (RMTI) United States $0.174B 0.00
United Health Products (UEEC) United States $0.170B 0.00
Owens & Minor (OMI) United States $0.166B 3.52
Fonar (FONR) United States $0.142B 7.49
Female Health (VERU) United States $0.134B 0.00
Chembio Diagnostics (CEMI) United States $0.103B 0.00
United-Guardian (UG) United States $0.092B 20.16
Surface Oncology (SURF) United States $0.076B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.067B 0.00
Trinity Biotech (TRIB) Ireland $0.053B 18.33
ImmuCell (ICCC) United States $0.044B 0.00
Senestech (SNES) United States $0.038B 0.00
GUARDION HEALTH (GHSI) United States $0.037B 0.00
Capricor Therapeutics (CAPR) United States $0.020B 0.00
Valeritas Holdings (VLRX) United States $0.014B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00